Answers are grounded in this paper and cite their sources.
The 14-valent pneumococcal vaccine, Pneumovax, was found to contain approximately 25o micrograms per ml of the cell-wall antigen, C-polysaccharide (C-Ps), in addition to 100 micrograms per ml of each of the 14 capsular polysaccharides. Rabbit anti-C-Ps antiserum recognized four components of this C-Ps with different antigenic determinants, corresponding to four fragments with different molecular sizes. By lectin affinity chromatography it was demonstrated that some of the C-Ps in the vaccine contained cell-wall residues. The methods used in this study can also be used for the characterization of other polysaccharide preparations.
No takes yet. Share an insight, caveat, or question.
Sørensen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: